Takeda appoints JPMorgan Chase to explore EUR 1bn European over-the-counter assets sale - report
29 OCT 2018
Takeda Pharmaceutical [TYO:4502] is discussing with JPMorgan Chase on a possible sale of EUR 1bn (USD 1.1bn) European over-the-counter assets, a newswire reported, citing sources privy to the process.
According to Reuters, the Japan-based company is exploring divestitures to cut the debt from its Shire Plc's[LON:SHP] USD 62bn acquisition.
The sale could be launched next year near, though no decision has been taken yet, the report added.